Staging of carcinoma of the breast using a hand-held gamma detecting probe and monoclonal antibody B72.3.
Radioimmunoguided Surgery (RIGS) uses a hand-held gamma detecting probe to identify radiolabeled monoclonal antibodies (Mab). Fourteen patients with carcinoma of the breast proved at biopsy received Mab B72.3 (5 millicuries of 125I per 1 milligram, Iodo-Gen method) intravenously six to 26 days before exploration. Probe counts were measured intraoperatively in mammary tissue and axillary lymph nodes. In the mammary tissue, the RIGS system identified tumor that was histologically confirmed in seven of eight patients and confirmed the absence in four of six patients. Probe counts were suspicious for tumor that was not proved histologically in two of 14 patients. Unsuspected tumor was identified in three of 14 patients. In axillary tissue, probe counts identified one of two tumors that were confirmed histologically and verified the absence of tumor in eight of 12 patients. Probe counts in axillary tissue were suspicious for tumor that could not be documented histologically in four of 14 patients. RIGS appears to be able to identify residual, subclinical and multicentric carcinoma of the breast and accurately delineate the pattern of antigenic drainage of tumor into adjacent lymph nodes.
Nieroda
C A
CA
Department of Surgery, Ohio State University College of Medicine, Columbus 43210.
Mojzisik
C
C
Sardi
A
A
Farrar
W B
WB
Hinkle
G
G
Siddiqi
M A
MA
Ferrara
P J
PJ
James
A
A
Schlom
J
J
Thurston
M O
MO
D000911:Antibodies, Monoclonal; D001943:Breast Neoplasms / Q000473:pathology*; D005260:Female; D005720:Gamma Rays; D006801:Humans; D007457:Iodine Radioisotopes; D008207:Lymphatic Metastasis; D009367:Neoplasm Staging; D011237:Predictive Value of Tests; D011874:Radiometry / Q000295:instrumentation*
D000911:Antibodies, Monoclonal; D007457:Iodine Radioisotopes